BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Pelthos Therapeutics Inc. (NYSE:PTHS)

1 post

Biotech NewsPelthos Therapeutics (PTHS): Zero Debt, $50M in Cash, and an FDA Greenlight—What’s Not to Love?

  • BioTech Health X
  • July 4, 2025
Pelthos Therapeutics Inc. (NYSE:PTHS) is a newly minted, revenue-ready biopharmaceutical company that sprang to life on July 2,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Wall Street’s Best-Kept Biotech Secret? Why Pharvaris (PHVS) Could Be the Next $3 Billion Breakout
  • Is Candel Therapeutics (CADL) the Next Big Cancer Stock? Analysts Say Yes—And It’s Still Cheap
  • This Tiny Biotech Just Spiked 239%—Here’s Why BioNexus (BGLC) Could Go Even Higher
  • Forget the Headlines — Anavex (AVXL)’s Alzheimer’s Drug Could Change Everything
  • From Penny Stock to Powerhouse? AIM ImmunoTech (AIM)’s Comeback Could Be Epic
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • July 4, 2025
    Wall Street’s Best-Kept Biotech Secret? Why Pharvaris (PHVS) Could Be the Next $3 Billion Breakout
    • July 4, 2025
    Is Candel Therapeutics (CADL) the Next Big Cancer Stock? Analysts Say Yes—And It’s Still Cheap
    • July 4, 2025
    This Tiny Biotech Just Spiked 239%—Here’s Why BioNexus (BGLC) Could Go Even Higher
    • July 4, 2025
    Forget the Headlines — Anavex (AVXL)’s Alzheimer’s Drug Could Change Everything
    • July 4, 2025
    From Penny Stock to Powerhouse? AIM ImmunoTech (AIM)’s Comeback Could Be Epic
Recent Posts
  • GlaxoSmithKline (GSK)’s Reinvention is Complete—Will This Drug Giant Deliver 50% Upside in 2025?
    • July 4, 2025
  • Abeona (ABEO) Could Be Wall Street’s Next Biotech Darling
    • July 4, 2025
  • Biotech Bargain Alert: Theravance Biopharma (TBPH) May Offer Triple-Digit Upside in 2025
    • July 4, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (236)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top